# Effect of Remimazolam on Postoperative Nausea and Vomiting

> **NCT05439057** · NA · COMPLETED · sponsor: **Inje University** · enrollment: 108 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT05439057
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-13
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05439057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05439057, "Effect of Remimazolam on Postoperative Nausea and Vomiting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05439057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*